[1] Mourad MM, Evans R, Kalidindi V, Navaratnam R, Dvorkin L, Bramhall SR. Prophylactic antibiotics in acute pancreatitis: endless debate. Annals of the Royal College of Surgeons of England 2017;99:107-12.
[2] van Dijk SM, Hallensleben NDL, van Santvoort HC, Fockens P, van Goor H, Bruno MJ, et al. Acute pancreatitis: recent advances through randomised trials. Gut 2017;66:2024-32.
[3] Wolbrink DRJ, Kolwijck E, Ten Oever J, Horvath KD, Bouwense SAW, Schouten JA. Management of infected pancreatic necrosis in the intensive care unit: a narrative review. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2020;26:18-25.
[4] Ma HX, He L, Cai SW, Xin XL, Shi HD, Zhou L, et al. [Analysis of the spectrum and resistance of pathogen causing sepsis in patients with severe acute pancreatitis]. Zhonghua wai ke za zhi [Chinese journal of surgery] 2017;55:378-83.
[5] Mallédant Y, Malbrain ML, Reuter DA. What's new in the management of severe acute pancreatitis? Intensive care medicine 2015;41:1957-60.
[6] Tugal D, Lynch M, Hujer AM, Rudin S, Perez F, Bonomo RA. Multi-drug-resistant Klebsiella pneumoniae pancreatitis: a new challenge in a serious surgical infection. Surgical infections 2015;16:188-93.
[7] Petrov MS, Shanbhag S, Chakraborty M, Phillips AR, Windsor JA. Organ failure and infection of pancreatic necrosis as determinants of mortality in patients with acute pancreatitis. Gastroenterology 2010;139:813-20.
[8] van Santvoort HC, Bakker OJ, Bollen TL, Besselink MG, Ahmed Ali U, Schrijver AM, et al. A conservative and minimally invasive approach to necrotizing pancreatitis improves outcome. Gastroenterology 2011;141:1254-63.
[9] IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology : official journal of the International Association of Pancreatology (IAP) [et al] 2013;13:e1-15.
[10] Hu Y, Jiang X, Li C, Cui Y. Outcomes from different minimally invasive approaches for infected necrotizing pancreatitis. Medicine 2019;98:e16111.
[11] Hu Y, Li C, Zhao X, Cui Y. An endoscopic or minimally invasive surgical approach for infected necrotizing pancreatitis: a systematic review and meta-analysis. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 2019;111:471-80.
[12] Mowbray NG, Ben-Ismaeil B, Hammoda M, Shingler G, Al-Sarireh B. The microbiology of infected pancreatic necrosis. Hepatobiliary & pancreatic diseases international : HBPD INT 2018;17:456-60.
[13] Baron EJ, Miller JM, Weinstein MP, Richter SS, Gilligan PH, Thomson RB, Jr., et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2013 recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a). Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;57:e22-e121.
[14] Jiang X, Shi JY, Wang XY, Hu Y, Cui YF. The impacts of infectious complications on outcomes in acute pancreatitis: a retrospective study. Military Medical Research 2020;7:38.
[15] Manes G, Rabitti PG, Menchise A, Riccio E, Balzano A, Uomo G. Prophylaxis with meropenem of septic complications in acute pancreatitis: a randomized, controlled trial versus imipenem. Pancreas 2003;27:e79-83.
[16] Trudel JL, Wittnich C, Brown RA. Antibiotics bioavailability in acute experimental pancreatitis. Journal of the American College of Surgeons 1994;178:475-9.
[17] Tian H, Chen L, Wu X, Li F, Ma Y, Cai Y, et al. Infectious Complications in Severe Acute Pancreatitis: Pathogens, Drug Resistance, and Status of Nosocomial Infection in a University-Affiliated Teaching Hospital. Digestive diseases and sciences 2020;65:2079-88.
[18] Baron TH, DiMaio CJ, Wang AY, Morgan KA. American Gastroenterological Association Clinical Practice Update: Management of Pancreatic Necrosis. Gastroenterology 2020;158:67-75.e1.
[19] Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, et al. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013;62:102-11.
[20] Shapiro NI, Wolfe RE, Wright SB, Moore R, Bates DW. Who needs a blood culture? A prospectively derived and validated prediction rule. The Journal of emergency medicine 2008;35:255-64.
[21] Canzoneri CN, Akhavan BJ, Tosur Z, Andrade PEA, Aisenberg GM. Follow-up Blood Cultures in Gram-Negative Bacteremia: Are They Needed? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2017;65:1776-9.
[22] Coburn B, Morris AM, Tomlinson G, Detsky AS. Does this adult patient with suspected bacteremia require blood cultures? Jama 2012;308:502-11.
[23] Vazirani J, Wurity S, Ali MH. Multidrug-Resistant Pseudomonas aeruginosa Keratitis: Risk Factors, Clinical Characteristics, and Outcomes. Ophthalmology 2015;122:2110-4.
[24] Venier AG, Leroyer C, Slekovec C, Talon D, Bertrand X, Parer S, et al. Risk factors for Pseudomonas aeruginosa acquisition in intensive care units: a prospective multicentre study. The Journal of hospital infection 2014;88:103-8.
[25] Werge M, Novovic S, Roug S, Knudsen JD, Feldager E, Gluud LL, et al. Evaluation of local instillation of antibiotics in infected walled-off pancreatic necrosis. Pancreatology : official journal of the International Association of Pancreatology (IAP) [et al] 2018;18:642-6.
[26] Sonmezer MC, Ertem G, Erdinc FS, Kaya Kilic E, Tulek N. Evaluation of Risk Factors for Antibiotic Resistance in Patients with Nosocomial Infections Caused by Pseudomonas aeruginosa. 2016;2016:1321487.
[27] Lee HS, Lee SK, Park DH, Lee SS, Seo DW, Kim MH, et al. Emergence of multidrug resistant infection in patients with severe acute pancreatitis. Pancreatology : official journal of the International Association of Pancreatology (IAP) [et al] 2014;14:450-3.
[28] Bobenchik AM, Deak E, Hindler JA, Charlton CL, Humphries RM. Performance of Vitek 2 for antimicrobial susceptibility testing of Enterobacteriaceae with Vitek 2 (2009 FDA) and 2014 CLSI breakpoints. Journal of clinical microbiology 2015;53:816-23.
[29] Iskander KN, Osuchowski MF, Stearns-Kurosawa DJ, Kurosawa S, Stepien D, Valentine C, et al. Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding. Physiological reviews 2013;93:1247-88.
[30] Novotny AR, Reim D, Assfalg V, Altmayr F, Friess HM, Emmanuel K, et al. Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis. Immunobiology 2012;217:616-21.
[31] Yong FJ, Mao XY, Deng LH, Zhang MM, Xia Q. Continuous regional arterial infusion for the treatment of severe acute pancreatitis: a meta-analysis. Hepatobiliary & pancreatic diseases international : HBPD INT 2015;14:10-7.
[32] da Costa DW, Boerma D, van Santvoort HC, Horvath KD, Werner J, Carter CR, et al. Staged multidisciplinary step-up management for necrotizing pancreatitis. The British journal of surgery 2014;101:e65-79.
[33] Peng Y, Bi J, Shi J, Li Y, Ye X, Chen X, et al. Multidrug-resistant Pseudomonas aeruginosa infections pose growing threat to health care-associated infection control in the hospitals of Southern China: a case-control surveillance study. American journal of infection control 2014;42:1308-11.
[34] Huang X, Li G, Yi L, Li M, Wang J. [The epidemiology of multidrug-resistant bacteria colonization and analysis of its risk factors in intensive care unit]. Zhonghua wei zhong bing ji jiu yi xue 2015;27:667-71.
[35] Fishman JE, Levy G, Alli V, Zheng X, Mole DJ, Deitch EA. The intestinal mucus layer is a critical component of the gut barrier that is damaged during acute pancreatitis. Shock (Augusta, Ga) 2014;42:264-70.
[36] Su MS, Lin MH, Zhao QH, Liu ZW, He L, Jia N. Clinical study of distribution and drug resistance of pathogens in patients with severe acute pancreatitis. Chinese medical journal 2012;125:1772-6.
[37] Howard TJ, Temple MB. Prophylactic antibiotics alter the bacteriology of infected necrosis in severe acute pancreatitis. Journal of the American College of Surgeons 2002;195:759-67.
[38] Soares FS, Amaral FC, Silva NLC, Valente MR, Santos LKR, Yamashiro LH, et al. Antibiotic-Induced Pathobiont Dissemination Accelerates Mortality in Severe Experimental Pancreatitis. Frontiers in immunology 2017;8:1890.
[39] Tan C, Ling Z, Huang Y, Cao Y, Liu Q, Cai T, et al. Dysbiosis of Intestinal Microbiota Associated With Inflammation Involved in the Progression of Acute Pancreatitis. Pancreas 2015;44:868-75.
[40] Trecarichi EM, Giuliano G, Cattaneo C, Ballanti S, Criscuolo M, Candoni A, et al. Bloodstream infections caused by Escherichia coli in onco-haematological patients: Risk factors and mortality in an Italian prospective survey. 2019;14:e0224465.
[41] Lai CC, Chen CC, Lu YC, Chuang YC, Tang HJ. In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Infection and drug resistance 2019;12:25-9.
[42] Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology. International journal of antimicrobial agents 2015;45:568-85.
[43] Ambrose PG, Lomovskaya O, Griffith DC, Dudley MN, VanScoy B. β-Lactamase inhibitors: what you really need to know. Current opinion in pharmacology 2017;36:86-93.
[44] Wang JT, Chang SC, Wang HY, Chen PC, Shiau YR, Lauderdale TL. High rates of multidrug resistance in Enterococcus faecalis and E. faecium isolated from inpatients and outpatients in Taiwan. Diagnostic microbiology and infectious disease 2013;75:406-11.
[45] Otto M. Staphylococcus epidermidis pathogenesis. Methods in molecular biology (Clifton, NJ) 2014;1106:17-31.
[46] Ukai T, Shikata S, Inoue M, Noguchi Y, Igarashi H, Isaji S, et al. Early prophylactic antibiotics administration for acute necrotizing pancreatitis: a meta-analysis of randomized controlled trials. Journal of hepato-biliary-pancreatic sciences 2015;22:316-21.
[47] Tenner S, Baillie J, DeWitt J, Vege SS. American College of Gastroenterology guideline: management of acute pancreatitis. The American journal of gastroenterology 2013;108:1400-15; 16.
[48] Schwender BJ, Gordon SR, Gardner TB. Risk factors for the development of intra-abdominal fungal infections in acute pancreatitis. Pancreas 2015;44:805-7.